CEO Shankar Musunuri said that the company is “on track” to meet its goal of submitting applications to the FDA requesting approval for the distribution of three of its products in the next three years.
The company said that 66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational oral Icotrokinra achieved site-specific clear or almost clear skin at week 16.
CEO Andrew Rees said the new global trade environment and business and consumer uncertainty have made it challenging to predict how consumers may respond.
The combination of Avutometinib capsules and Defactinib tablets, under the brand name Avmapki Fakzynja Co-pack, can now be used to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior treatment.
The firm increased its full-year adjusted EPS guidance to $2.16 to $2.30 from its previous guidance of $2.12 to $2.26, including the impact of share repurchases.
The company expects the acquisition to add diversity and durability to its trading revenues, given that options trading revenues are typically less cyclical than spot trading.
The company raised its full-year revenue guidance to between $975 million and $1.025 billion, up from its previous guidance of between $300 million and $350 million.
According to a Bloomberg report, Prashanth Menon is stepping down from his position as chairman of Tesla India’s board after serving in the role for over four years.
The company also reaffirmed its full year outlook including total revenue of $11.2 billion to $11.3 billion, a medical loss ratio of 80.7% to 81.7%, and earnings from operations of $225 million to $275 million.
A Reuters report said Ford is increasing the prices of the Mustang Mach-E electric SUV, the Maverick pickup, and Bronco Sport by as much as $2,000, effective May 2.
The company website lists the starting price of the new long-range rear-wheel drive variant of the vehicle as $44,990, not including the federal tax credit of $7,500 available on the purchase of select electric vehicles.
The company reported net revenue of $39.1 million for the first quarter from the sales of DefenCath, above an analyst estimate of $36, as per Finchat data.
